The WiseTech Global Ltd (ASX: WTC) share price has jumped 6% after the ASX tech share announced the newest member of its leadership team.WiseTech is a global software business which provides technology for many of the world’s largest freight and logistics businesses. Its key software offering is called CargoWise.New independent director appointmentWiseTech announced to the market that it has appointed Raelene Murphy to the board of the company as an additional independent non-executive director, starting fr ...

-  Enters co-operation agreement with Plantro Ltd.-  Accelerates ongoing board renewal process- Forms special committee to oversee the execution of actions related to non-core assets, to include participation by special advisor recommended by Plantro OTTAWA, Ontario, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY) (“Calian” or the “Company”), a mission-critical solutions company focused on defence, space, healthcare and other strategic critical infrastructure sectors, announces that it is acc ...

Core Insights - Calian Group Ltd. is accelerating its board renewal process and has formed a special committee to oversee actions related to non-core assets, following a cooperation agreement with Plantro Ltd., a significant shareholder [1][6] Board Renewal Process - The board renewal process includes the retirement of George Weber and Kevin Ford, with Jo-Anne Poirier also not seeking re-election [3] - New board members Lisa Greatrix, Josh Blair, and Eric Demirian were added earlier this year, and incoming CEO Patrick Houston will join the board on January 1, 2026 [4] Focus on Non-Core Assets - Calian has identified certain non-core assets for divestiture as part of a portfolio review, and a temporary committee of independent directors has been formed to oversee these initiatives [5] - The committee includes Josh Blair, Eric Demirian, and Val Sorbie, with Stephen Halperin acting as a special advisor [5] Cooperation Agreement with Plantro - The cooperation agreement with Plantro includes commitments to accelerate board renewal and establish the independent committee, along with standstill and non-disparagement provisions effective until November 1, 2026 [6] - This agreement reflects Calian's commitment to constructive engagement with shareholders [6] Strategic Opportunities - The board and management team are focused on executing a refined strategy to capitalize on significant opportunities in the defense and related sectors, driven by anticipated increases in defense spending [2]

Group 1 - The chair of Novo Nordisk and six independent board members will resign due to a strategic dispute with the controlling shareholder, the Novo Nordisk Foundation [1][3] - The Foundation plans to propose Lars Rebien Sorensen as the temporary chairman for a period of two to three years [2] - The company has undergone significant leadership changes, including the ousting of CEO Lars Fruergaard Jorgensen and the initiation of a restructuring plan involving 9,000 job cuts [2] Group 2 - The board renewal is deemed necessary by the Foundation to adapt to the rapidly changing environment in the obesity drug market [3] - There was a lack of consensus between the board and the Foundation regarding the extent of the board renewal, with the board favoring selective additions and the Foundation advocating for a more comprehensive reconfiguration [4] - Helge Lund has served as chair of Novo's board since 2018 [4]